Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 21, 2024 09:35 ET | Source: DepYmed, Inc.

DepYmed to Meet with Investors at the BIO CEO and Investor Conference

FARMINGDALE, N.Y., Feb. 21, 2024 (GLOBE NEWSWIRE) -- DepYmed, Inc. (“DepYmed” or the “Company”) is a preclinical stage pharmaceutical company focused on developing transformative treatments for rare...
February 15, 2024 08:00 ET | Source: Indaptus Therapeutics

Indaptus Therapeutics to Present at the 2024 BIO CEO & Investor Conference

NEW YORK, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP), a clinical stage biotechnology company dedicated to pioneering innovative cancer and viral infection...